Precipio Free Cash Flow 2010-2025 | PRPO
Precipio free cash flow from 2010 to 2025. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Precipio Annual Free Cash Flow | |
|---|---|
| 2024 | 0.22 |
| 2023 | -3.69 |
| 2022 | -8.00 |
| 2021 | -7.26 |
| 2020 | -7.53 |
| 2019 | -9.20 |
| 2018 | -6.85 |
| 2017 | -6.83 |
| 2016 | -0.96 |
| 2015 | -12.58 |
| 2014 | -13.83 |
| 2013 | -9.08 |
| 2012 | -11.09 |
| 2011 | -0.01 |
| 2010 | -1.91 |
| 2009 | 0.92 |
| Precipio Quarterly Free Cash Flow | |
|---|---|
| 2025-03-31 | -0.18 |
| 2024-12-31 | 0.22 |
| 2024-09-30 | -0.31 |
| 2024-06-30 | -0.24 |
| 2024-03-31 | -0.67 |
| 2023-12-31 | -3.69 |
| 2023-09-30 | -3.75 |
| 2023-06-30 | -2.83 |
| 2023-03-31 | -1.60 |
| 2022-12-31 | -8.00 |
| 2022-09-30 | -6.45 |
| 2022-06-30 | -4.09 |
| 2022-03-31 | -2.34 |
| 2021-12-31 | -7.26 |
| 2021-09-30 | -5.76 |
| 2021-06-30 | -3.33 |
| 2021-03-31 | -1.45 |
| 2020-12-31 | -7.53 |
| 2020-09-30 | -6.05 |
| 2020-06-30 | -3.57 |
| 2020-03-31 | -1.61 |
| 2019-12-31 | -9.20 |
| 2019-09-30 | -7.05 |
| 2019-06-30 | -4.92 |
| 2019-03-31 | -1.88 |
| 2018-12-31 | -6.85 |
| 2018-09-30 | -4.87 |
| 2018-06-30 | -3.66 |
| 2018-03-31 | -1.15 |
| 2017-12-31 | -6.83 |
| 2017-09-30 | -4.48 |
| 2017-06-30 | -0.90 |
| 2017-03-31 | -0.33 |
| 2016-12-31 | -0.96 |
| 2016-09-30 | -0.64 |
| 2016-06-30 | -0.39 |
| 2016-03-31 | -1.94 |
| 2015-12-31 | -12.58 |
| 2015-09-30 | -9.72 |
| 2015-06-30 | -6.21 |
| 2015-03-31 | -3.52 |
| 2014-12-31 | -13.83 |
| 2014-09-30 | -11.33 |
| 2014-06-30 | -7.37 |
| 2014-03-31 | -3.91 |
| 2013-12-31 | -9.08 |
| 2013-09-30 | -6.84 |
| 2013-06-30 | -6.04 |
| 2013-03-31 | -3.42 |
| 2012-12-31 | -11.09 |
| 2012-09-30 | -8.42 |
| 2012-06-30 | -5.56 |
| 2012-03-31 | -2.96 |
| 2011-12-31 | -0.01 |
| 2011-09-30 | -1.05 |
| 2011-06-30 | -0.13 |
| 2011-03-31 | -0.04 |
| 2010-12-31 | -1.91 |
| 2010-09-30 | -1.03 |
| 2010-06-30 | -0.14 |
| 2010-03-31 | 0.35 |
| 2009-12-31 | 0.92 |
| 2009-09-30 | -0.09 |
| 2009-06-30 | -0.03 |
| 2009-03-31 | 0.09 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.022B | $0.019B |
| Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.130B | 58.69 |
| Doximity (DOCS) | United States | $11.290B | 52.27 |
| Hims & Hers Health (HIMS) | United States | $11.277B | 117.16 |
| Tempus AI (TEM) | United States | $10.557B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.350B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.741B | 58.45 |
| Hinge Health (HNGE) | United States | $3.664B | 0.00 |
| Privia Health (PRVA) | United States | $2.391B | 163.42 |
| Schrodinger (SDGR) | United States | $1.574B | 0.00 |
| Phreesia (PHR) | United States | $1.516B | 0.00 |
| Enovis (ENOV) | United States | $1.502B | 8.37 |
| Clover Health Investments (CLOV) | United States | $1.496B | 0.00 |
| 10x Genomics (TXG) | United States | $1.496B | 0.00 |
| Azenta (AZTA) | United States | $1.427B | 66.30 |
| Omnicell (OMCL) | United States | $1.259B | 22.22 |
| Evolent Health (EVH) | United States | $1.119B | 95.30 |
| Claritev (CTEV) | United States | $0.702B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.541B | 0.00 |
| Veradigm (MDRX) | United States | $0.531B | 0.00 |
| Standard BioTools (LAB) | United States | $0.467B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.462B | 0.00 |
| Talkspace (TALK) | United States | $0.415B | 124.00 |
| TruBridge (TBRG) | United States | $0.336B | 746.33 |
| Outset Medical (OM) | United States | $0.309B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.280B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.254B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.248B | 0.00 |
| CapsoVision (CV) | United States | $0.211B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.191B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.155B | 0.00 |
| Pulmonx (LUNG) | United States | $0.127B | 0.00 |
| American Well (AMWL) | United States | $0.126B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.117B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.114B | 0.00 |
| CareCloud (CCLD) | United States | $0.101B | 3.85 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.082B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.079B | 0.00 |
| 111 (YI) | China | $0.066B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.048B | 0.00 |
| HeartBeam (BEAT) | United States | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |